Open Access
Subscription or Fee Access
Role of Plant-based Natural Products in the Treatment of Type 2 Diabetes
Abstract
Diabetes mellitus is caused by the elevation of blood sugar levels and has become a serious health concern worldwide with the number of cases steadily increasing annually. Due to the increased side effects and costs associated with the use of conventional drugs, alternative treatment methods that use natural compounds from medicinal plants have been researched. This review summarizes the recent advances and discoveries of plant based natural compounds used for the treatment of Type 2 diabetes as well as their mechanisms of action, which include the inhibition of carbohydrate metabolizing enzymes, reducing oxidative stress, modifying the activity of the PPARγ receptor, and modifying the activity of glucose transporters. We also describe the most prevalent classes of chemical compounds that have been shown to exhibit significant antidiabetic activity, thereby showing promise for development into novel drug molecules. These classes include polysaccharides, polyphenols, alkaloids, terpenes and quinones among others.
.
Keywords
References
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157:107843p.
Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020; 16(7):377–90p.
Genco RJ, Borgnakke WS. Diabetes as a potential risk for periodontitis: association studies. Periodontol 2000. 2020; 83(1):40–45p.
Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018; 14(2):99–114p.
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia–A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev. 2020; 14(4):395–403p.
Agrawal S, Dimitrova N, Nathan P, et al. T2D-Db: An integrated platform to study the molecular basis of Type 2 diabetes. BMC Genomics. 2008; 9(1):1–12p.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: A review of current trends. Oman Med J. 2012; 27(4): 269–73p.
Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013; 04: 37p.
Choudhury H, Pandey M, Hua CK, et al. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. J Tradit Complement Med. 2018; 8(3):361–376p.
Elavarasi S, Saravanan K, Renuka C. A systematic review on medicinal plants used to treat diabetes mellitus. Int J Pharm Chem Biol Sci. 2013; 3(3):983–992p.
Nisar B, Sultan A, Rubab SL. Comparison of Medicinally Important Natural Products versus Synthetic Drugs-A Short Commentary. Nat Prod Chem Res. 2018; 06(02): 1-2p.
Atanasov AG, Zotchev SB, Dirsch VM. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20(3):200–216p.
Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015; 33(8):1582–1614p.
Gonzalez-Burgos E, Gomez-Serranillos MP. Terpene Compounds in Nature: A Review of Their Potential Antioxidant Activity. Curr Med Chem. 2012; 19(31):5319–5341p.
Germoush MO, Elgebaly HA, Hassan S, et al. Consumption of terpenoids-rich padina pavonia extract attenuates hyperglycemia, insulin resistance and oxidative stress, and upregulates pparγ in a rat model of Type 2 diabetes. Antioxidants. 2020; 9(1): 1–24p.
Panigrahy SK, Bhatt R, Kumar A. Targeting Type 2 diabetes with plant terpenes: the new and promising antidiabetic therapeutics. Biologia. 2021; 76(1):241–254p.
Jeppesen PB, Gregersen S, Alstrup KK, et al. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: Studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine. 2002; 9(1):9–14p.
Chang C, Chou C, Liao M, et al. Bitter melon triterpenes work as insulin sensitizers and insulin substitutes in insulin-resistant cells. J Funct Foods. 2015; 13: 214–224p.
Kumar D, Ghosh R, Pal BC. α-Glucosidase inhibitory terpenoids from Potentilla fulgens and their quantitative estimation by validated HPLC method. J Funct Foods. 2013; 5(3):1135–1141p.
Majouli K, Besbes Hlila M, Hamdi A, et al. Antioxidant activity and α-glucosidase inhibition by essential oils from Hertia cheirifolia (L.). Ind Crops Prod. 2016; 82: 23–28p.
Panigrahy SK, Bhatt R, Kumar A. Reactive oxygen species: sources, consequences and targeted therapy in Type 2 diabetes. J Drug Target. 2017; 25(2): 93–101p.
Samarghandian S, Borji A, Delkhosh MB, et al. Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J Pharm Pharm Sci. 2013; 16(2): 352–362p.
Krauss RM. Lipids and lipoproteins in patients with Type 2 diabetes. Diabetes Care. 2004; 27(6):1496–1504p.
Güder A. Influence of total anthocyanins from bitter melon (Momordica charantia Linn.) as antidiabetic and radical scavenging agents. Iran J Pharm Res. 2016; 15(1):1–21p.
Brewer PD, Habtemichael EN, Romenskaia I, et al. Insulin-regulated Glut4 translocation: Membrane protein trafficking with six distinctive steps. J Biol Chem. 2014; 289(25):17280–17298p.
Umeno A, Horie M, Murotomi K, Nakajima Y, Yoshida Y. Antioxidative and Antidiabetic Effects of Natural Polyphenols and Isoflavones. Molecules. 2016; 21: 1–15p.
Gulcin I, Kaya R, Goren AC, et al. Anticholinergic, antidiabetic and antioxidant activities of cinnamon (Cinnamomum verum) bark extracts : polyphenol contents analysis by LC-MS/MS. Int J Food Prop. 2019; 22(1):1511–1526p.
Ma Q, Guo Y, Sun L, et al. Anti-Diabetic Effects of Phenolic Extract from Rambutan Peels (Nephelium lappaceum) in High-Fat Diet and Streptozotocin-Induced Diabetic Mice. Nutrients. 2017; 9(8): 1-12p.
Ruth O, Hamid N, Ishmael C. Vernonia cinerea leaves as the source of phenolic compounds, antioxidants, and anti-diabetic activity using microwave-assisted extraction technique. Ind Crop Prod. 2018; 122:533–544p.
De Silva ABKH, Rupasinghe HPV. Polyphenols composition and anti-diabetic properties in vitro of haskap (Lonicera caerulea L.) berries in relation to cultivar and harvesting date. J Food Compos Anal. 2020; 88:1-10p.
Mollica A, Zengin G, Locatelli M, et al. Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: In vivo and in vitro evaluation of its nutraceutical potential. J Funct Foods. 2017; 35: 32–42p.
Das B, De A, Das M, et al. A new exploration of Dregea volubilis flowers: Focusing on antioxidant and antidiabetic properties. South African J Bot. 2017; 109:16–24p.
Hu F, Li X, Zhao L, et al. Antidiabetic properties of purified polysaccharide from Hedysarum polybotrys. Can J Physiol Pharm. 2010; 88(1):64–72p.
Xu Y, Niu X, Liu N, et al. Characterization, antioxidant and hypoglycemic activities of degraded polysaccharides from blackcurrant (Ribes nigrum L.) fruits. Food Chem. 2018; 243:26–35p.
Feriani A, Tir M, Hamed M, et al. Multidirectional insights on polysaccharides from Schinus terebinthifolius and Schinus molle fruits: Physicochemical and functional profiles, in vitro antioxidant, anti-genotoxicity, antidiabetic, and antihemolytic capacities, and in vivo anti-inflammator. Int J Biol Macromol. 2020; 165: 2576-2587p.
Meng Q, Chen F, Xiao T, et al. Inhibitory effects of polysaccharide from Diaphragma juglandis fructus on α-amylase and α-D-glucosidase activity, streptozotocin-induced hyperglycemia model, advanced glycation end-products formation, and H2O2-induced oxidative damage. Int J Biol Macromol. 2019; 124:1080–1089p.
Wang Q, Wu X, Shi F, et al. Biomedicine & Pharmacotherapy Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced Type 2 diabetic mice. Biomed Pharmacother. 2018; 109:744–750p.
Bai Z, Meng J, Huang X, et al. Comparative study on antidiabetic function of six legume crude polysaccharides. Int J Biol Macromol. 2020; 154: 25-30p.
Amarnath SM, Pari L. Antioxidant effect of Boerhavia diffusa L. in tissues of alloxan induced diabetic rats. Indian J Exp Biol. 2004; 42(10):989-992p.
Ananthi J, Prakasam A, Pugalendi KV. Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats. Yale J Biol Med. 2003; 76(3):97–102p.
Agrawal R, Sethiya NK, Mishra SH. Antidiabetic activity of alkaloids of Aerva lanata roots on streptozotocin-nicotinamide induced Type 2 diabetes in rats. Pharm Biol. 2013; 51(5):635–642p.
Ogunlana OO, Adetuyi BO, Rotimi M, et al. Hypoglycemic and antioxidative activities of ethanol seed extract of Hunteria umbellate (Hallier F.) on streptozotocin-induced diabetic rats. Clin Phytoscience. 2021; 7(1):55-64p.
Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002; 81(1):81–100p.
Dulo B, Phan K, Githaiga J, et al. Natural Quinone Dyes: A Review on Structure, Extraction Techniques, Analysis and Application Potential. Waste Biomass Valor. 2021; doi.org/10.1007/s12649-021-01443-9
Qin L, Zhang X, Zhou X, et al. Protective effect of benzoquinone isolated from the roots of Averrhoa carambola L. on streptozotocin-induced diabetic mice by inhibiting the tlr4/nf-κb signaling pathway. Diabetes, Metab Syndr Obes Targets Ther. 2020; 13: 2129–2138p.
Chen X, Gao M, Jian R, et al. Design, synthesis and α-glucosidase inhibition study of novel embelin derivatives. J Enzyme Inhib Med Chem. 2020; 35(1): 565–573p.
Gaikwad SA. Phytochemical investigation of bioactive Emodin and quercetin in Cassia fistula and Cassia tora plant parts by HPTLC. J Pharmacogn Phytochem. 2018; 7(5):892–897p.
Chen Z, Zhang L, Yi J, et al. Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARγ-agonist activity. J Cell Biochem. 2012; 113(11):3547–3558p.
Li J, Ding L, Song B, et al. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. Eur J Pharmacol. 2016; 770: 99–109p.
Song P, Kim JH, Ghim J, et al. Emodin regulates glucose utilization by activating amp-activated protein kinase. J Biol Chem. 2013; 288(8):5732–5742p.
Wang Y, Su-ling H, Ying F, et al. Emodin, an 11β-hydroxysteroid dehydrogenase Type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice. Acta Pharmacol Sin. 2012; 33(9):1195–1203p.
Gebhardt R, Lerche KS, Götschel F, et al. 4-Aminoethylamino-emodin-a novel potent inhibitor of GSK-3β-acts as an insulin-sensitizer avoiding downstream effects of activated β-catenin. J Cell Mol Med. 2010; 14:1276–1293p.
Chao PM, Kuo YH, Lin YS, et al. The metabolic benefits of Polygonum hypoleucum Ohwi in HepG2 cells and wistar rats under lipogenic stress. J Agric Food Chem. 2010; 58(8):5174–5180p.
Zhao XY, Qiao GF, Li BX, et al. Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-type calcium channels in dyslipidaemic-diabetic rats. Clin Exp Pharmacol Physiol. 2009; 36(1):29–34p.
Arvindekar A, More T, Payghan PV, et al. Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi. Food Funct. 2015; 6(8):2693–2700p.
Shah MA, Keach JE, Panichayupakaranant P. Natural products chemistry of global tropical and subtropical plants. Chem Pharm Bull. 2018; 66(5):467–468p.
Nigorikawa K, Yoshikawa K, Sasaki T, et al. A naphthoquinone derivative, shikonin, has insulin-like actions by inhibiting both phosphatase and tensin homolog deleted on chromosome 10 and tyrosine phosphatases. Mol Pharmacol. 2006; 70(3):1143–1149p.
Brimson JM, Tencomnao T. Medicinal herbs and antioxidants: Potential of Rhinacanthus nasutus for disease treatment? Phytochem Rev. 2014; 13(3):643–651p.
Ajmal SM, Khalil R, Ul-Haq Z, et al. α-Glucosidase inhibitory effect of rhinacanthins-rich extract from Rhinacanthus nasutus leaf and synergistic effect in combination with acarbose. J Funct Foods. 2017; 36:325–331p.
Elekofehinti OO. Saponins: Anti-diabetic principles from medicinal plants-A review. Pathophysiology. 2015; 22(2):95–103p.
Elekofehinti OO, Kamdem JP, Kade IJ, et al. Hypoglycemic, antiperoxidative and antihyperlipidemic effects of saponins from Solanum anguivi Lam. fruits in alloxan-induced diabetic rats. South African J Bot. 2013; 88:56–61p.
Kwon DY, Kim YS, Ryu SY, et al. Platyconic acid, a saponin from Platycodi radix, improves glucose homeostasis by enhancing insulin sensitivity in vitro and in vivo. Eur J Nutr. 2011; 51(5):529–540p.
Metwally NS, Mohamed AM, El Sharabasy FS. Chemical constituents of the Egyptian plant Anabasis articulata (Forssk) Moq and its antidiabetic effects on rats with streptozotocininduced diabetic hepatopathy. J Appl Pharm Sci. 2012; 2(4):54–65p.
Bhavsar SK, Föller M, et al. Involvement of the PI3K/AKT pathway in the hypoglycemic effects of saponins from Helicteres isora. J Ethnopharmacol. 2009; 126(3): 386–396p.
Lee KT, Jung TW, Lee HJ, et al. The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Arch Pharm Res. 2011; 34(7):1201–1208p.
McAnuff-Harding MA, Omoruyi FO, Asemota HN. Intestinal disaccharidases and some renal enzymes in streptozotocin-induced diabetic rats fed sapogenin extract from bitter yam (Dioscorea polygonoides). Life Sci. 2006; 78(22):2595–2600p.
Santos CMM, Freitas M, Fernandes E. A comprehensive review on xanthone derivatives as α-glucosidase inhibitors. Eur J Med Chem. 2018; 157:1460–1479p.
Li H, Yao Y, Li L. Coumarins as potential antidiabetic agents. J Pharm Pharmacol. 2017; 69:1253–1264p.
Refbacks
- There are currently no refbacks.